Parkinson’s disease market

Jan 06, 2025

What is Parkinson's? Parkinson's disease is a progressive neurodegenerative disorder that primarily affects movement and coordination. It is a condition caused by the gradual loss of dopamine-producing neurons in the brain, leading to symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and p...

Dec 24, 2024

Parkinson’s disease is a complex neurodegenerative disorder that affects millions worldwide, with increasing prevalence as populations age. The market for Parkinson’s disease treatments is expanding rapidly, driven by rising awareness of what Parkinson’s disease is, advancements in research, and improvements in hea...

Dec 23, 2024

Parkinson's disease is a progressive neurodegenerative disorder that primarily affects movement, causing tremors, stiffness, and balance problems. The condition develops when nerve cells in the brain that produce dopamine, a chemical that helps control muscle movements, become damaged or die. As one of the most com...

Nov 18, 2024

Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It affects about 10 million people worldwide. The average age of onset for Parkinson’s disease is around 60; however, approximately 10-15% of patients experience early-onset PD before the age of 50. In 2023, there...

Dec 30, 2022

Parkinson’s disease (PD) is a degenerative neurological condition primarily affecting middle-aged and older adults and is characterized by tremors, muscular rigidity, and slow, clumsy movement. It is connected to the brain’s basal ganglia atrophy and a lack of the neurotransmitter dopamine. Levodopa is considered a...